SATMOBO
LIVE

Serial Number

79424973

Owner

TAIHO PHARMACEUTICAL CO., LTD.

Filing Date

Apr 22, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SATMOBO Trademark

Serial Number: 79424973 • Registration: 8217515

SATMOBO is a trademark filed by TAIHO PHARMACEUTICAL CO., LTD. on April 22, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TAIHO PHARMACEUTICAL CO., LTD. (107 trademarks)

CHIYODA-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

April 22, 2025

Registration Date

April 21, 2026

Published for Opposition

March 3, 2026

Goods & Services

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood, pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2026 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
PUBLISHED FOR OPPOSITION
Mar 3, 2026 PUBO
NOTICE OF PUBLICATION
Feb 25, 2026 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2026 CNSA
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2026 NWOS
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 4, 2025 CRCV
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 5, 2025 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 29, 2025 SDRC